Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists), SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H19FN2O |
InChIKeyFBWFMFJYAIKZIC-UHFFFAOYSA-N |
CAS Registry427889-61-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obsessive-Compulsive Disorder | Preclinical | FR | - | |
Obsessive-Compulsive Disorder | Preclinical | DE | - |